Advanced Oncotherapy #AVO – Exclusive distribution agreement for China and other geographies & new equity investments for a total consideration of £37m

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed an exclusive distribution agreement with Yantai CIPU Medical Technology Co. Ltd. to market and sell Advanced Oncotherapy’s LIGHT system across China, Macau, Taiwan, Hong-Kong and South Korea. Under the agreement, Yantai CIPU will make a payment of £16.5 […]

Combatting cancer in challenging environments – CERN

By Stephanie Hills – CERN. If you live in a low- or middle-income country, your chances of surviving cancer are significantly lower than if you live in a wealthier economy, and that’s largely due to the availability of radiation therapy. A group of international experts in the fields of accelerator design, medical physics and oncology […]

Advanced Oncotherapy (AVO) – Interim results announcement

Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and post-period events.  Highlights: ·     Technological milestones reached with successful integration and testing of proton source, RFQ and SCDTL significantly de-risking development process ·     Progress at the Harley Street […]